S100A9 and myocardial infarction: Moreover, the injection of mice with an S100A9 neutralizing antibody or inhibitor ABR-238901 effectively protects against cardiac damage and dysfunction after myocardial I/R and 7 days of MI 10, 24, 44, 45.